Ruikang Tao

Using Transcriptional Signatures to Find Cancer Drivers with LURE

Joshua M. Stuart, Christopher K. Wong, D. Haan, 2019, bioRxiv.

The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric Cancer

P. Zhang, G. Mills, J. Ajani, 2019, Molecular Cancer Therapeutics.

Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.

J. Bai, K. Tao, X. Shuai, 2018, Oncology reports.

Dissect the Dynamic Molecular Circuits of Cell Cycle Control through Network Evolution Model

G. Peng, R. Tao, P. Scott, 2017, BioMed research international.

Chk 1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN 673 in gastric cancer

G. Mills, J. Ajani, G. Peng, 2017 .

Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer.

G. Mills, J. Ajani, G. Peng, 2017, American journal of cancer research.

Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING‐dependent therapy‐induced senescence and provides “one‐two punch” opportunity with anti‐PD‐L1 therapy in colorectal cancer

K. Tao, Weizhen Liu, Tao Wang, 2023, Cancer science.